Assembly Biosciences (ASMB) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 5, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 4, 2025.

Voting matters and shareholder proposals

• Election of ten directors is on the agenda, with board recommendations for all nominees.

• Advisory vote on executive compensation (say-on-pay) is included.

• Amendments to the 2018 Stock Incentive Plan to increase shares reserved by 375,000 and 225,000 for retention grants.

• Amendment to the Employee Stock Purchase Plan to increase authorized shares to 225,000.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2025.

Board of directors and corporate governance

• Ten director nominees are listed for election, including individuals with medical, scientific, and financial expertise.